Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 815 results for "bristol myers squibb"

Bristol-Myers' (BMY) Yervoy Label Expanded in Canada

Yervoy is one of the most promising drugs in Bristol-Myers Squibb 's ( BMY ) portfolio. The drug has performed very well since its approval in the U.S. in 2011 as a monotherapy for treating patients suffering from unresectable or metastatic ... Yahoo! Finance, 1 day ago

53 images for bristol myers squibb

Jutia Group, 1 week ago
Pharma Letter, 1 week ago
Pharma Letter, 2 weeks ago
Dividend.com, 3 weeks ago
Jutia Group, 3 weeks ago
Pharmafocus, 1 week ago
Pharmaceutical Executive, 1 week ago
Jutia Group, 1 month ago
Irish Independent, 1 month ago
rttnews.com, 1 month ago

Why You Should Sell Bristol-Myers Squibb And Buy Johnson & Johnson Instead

Summary Bristol-Myers Squibb holds a very high valuation that is dangerous for investors. Even more dangerous is that Bristol-Myers Squibb's earnings are expected to decline this year, after declining last year as well. Meanwhile, Johnson & ...
 Seeking Alpha2 days ago Is It Time to Buy Dividend Stock Bristol-Myers Squibb Co?  Motley Fool3 days ago 3 Best Stocks to Invest in Pharma  Nasdaq2 days ago Bristol-Myers Squibb Company 's board to pay dividends  Individual.com4 days ago
[x]  

Bristol-Myers Squibb (BMY) Approaches New Upside Target of $51.67

Bristol-Myers Squibb (NYSE:BMY) has opened bullishly above the pivot of $51.16 today and has reached the first level of resistance at $51.39. Analysts will be watching for a cross of the next upside pivot targets of $51.67
 Individual.com2 days ago Bristol-Myers Squibb (BMY) Crosses Pivot Point Support at $49.96  Comtex SmarTrend5 days ago Next Resistance Level for Bristol-Myers Squibb (BMY) is $51.43  Individual.com3 days ago Bristol-Myers Squibb (BMY) Declares $0.36 Quarterly Dividend; 2.8% Yield  Town Hall4 days ago
[x]  

Cancer Research Institute to Honor Leaders in Cancer Immunotherapy

Murdo Gordon of Bristol-Myers Squibb and CRI Trustee Jacques C. Nordeman Will Receive the Oliver R. Grace Award at Cancer Research Institute's 28th Annual
 Big News Network4 days ago Call for Ideas Open for the Stand Up To Cancer-American Cancer Society Lung Cancer Translational Research Dream Team Grant  Noodls2 days ago

Bristol-Myers Squibb COO Unloads $1,331,080 in Stock (BMY)

Bristol-Myers Squibb (NYSE:BMY) COO Giovanni Caforio unloaded 26,691 shares of Bristol-Myers Squibb stock on the open market in a transaction dated Monday, September 15th. The stock was sold at an average price of $49.87, for a total transaction of ...
 American Banking News4 days ago Bristol-Myers Squibb COO Sells $1,331,080 in Stock (BMY)  Mideast Time3 days ago

BRISTOL MYERS SQUIBB : An Application for the Trademark "DASCERN" Has Been Filed by Bristol-Myers Squibb

By a News Reporter-Staff News Editor at Clinical Trials Week -- According to news reporting originating from Washington, D.C. , by NewsRx journalists, a trademark application has been made for "DASCERN" by Marilyn F. Kelly , representing ...
 4 Traders4 days ago BRISTOL MYERS SQUIBB : Trademark Application for "DASPERSE" Filed  4 Traders4 days ago The Consult Guys - Clean Coronaries But a Broken Heart  Annals of Internal Medicine5 days ago An Application for the Trademark "DASCERN" Has Been Filed by Bristol-Myers Squibb  Pharmacy Choice4 days ago

Insider Selling: Francis M. Cuss Sells 63,667 Shares of Bristol-Myers Squibb Stock (BMY)

Bristol-Myers Squibb (NYSE:BMY) EVP Francis M. Cuss sold 63,667 shares of the stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $50.77, for a total value of $3,232,373.59. Following the ...
 American Banking News4 days ago

Bristol-Myers Squibb Co Plans Quarterly Dividend of $0.36 (BMY)

Bristol-Myers Squibb (NYSE:BMY) announced a quarterly dividend on Tuesday, September 16th, AnalystRatings.Net reports. Stockholders of record on Friday, October 3rd will be paid a dividend of 0.36 per share on Monday, November 3rd. This represents a ...
 American Banking News4 days ago

Bristol-Myers Squibb to challenge Merck in skin cancer treatment arena, says GlobalData Analyst

Merck's Keytruda, which was recently approved in the US to treat patients with advanced melanoma, who have stopped responding to other cancer therapies, will soon face strong competition from Bristol-Myers Squibb's (BMS) Opdivo, says an analyst with ...
 European Pharmaceutical Review5 days ago BMS and Merck Race to Melanoma Treatment Market  Pharmaceutical Executive5 days ago

BRISTOL MYERS SQUIBB : Health Canada approves Yervoy® (ipilimumab) for first-line treatment of adults with metastatic melanoma, the most deadly form of skin cancer

Immunotherapy treatment with long-term survival in some previously treated patients now approved for use in newly diagnosed patients MONTREAL , Sept. 16, 2014 /CNW/ - Bristol-Myers Squibb Canada is pleased to announce that Health Canada has ...
 4 Traders5 days ago Health Canada approves Yervoy┬« (ipilimumab) for first-line treatment of adults with metastatic melanoma, the most deadly form of skin cancer  BusinessWeek5 days ago Health Canada approves Yervoy (ipilimumab) for first-line treatment of adults with metastatic melanoma, the most deadly form of skin cancer  FirstWord Pharma5 days ago Health Canada approves YervoyA(r) (ipilimumab) for first-line treatment of adults with metastatic melanoma, the most deadly form of skin cancer  Canada NewsWire5 days ago
[x]  
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - bristol myers squibb
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less